Company Filing History:
Years Active: 2016-2018
Title: Laurie Dumoutier: Innovator in Antibody Production
Introduction
Laurie Dumoutier is a notable inventor based in Orbais, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of antibody production. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Laurie Dumoutier's latest patents focus on a method for producing antibodies using a 'naked' expression vector that expresses a type II transmembrane fusion protein. The methods disclosed involve generating antibodies and an expression vector used to express proteins that provoke the antibody response. This expression vector is designed to generate an antibody directed to an antigen, comprising a gene in operable linkage with a promoter. The gene encodes a fusion protein that includes CD134L as the N-terminal moiety and an antigenic protein as the C-terminal moiety. By injecting this vector into a subject animal, a fusion protein is produced, which leads to the generation of antibodies.
Career Highlights
Laurie Dumoutier is currently associated with Delphi Genetics S.A., where he continues to advance his research in antibody production. His innovative approaches have garnered attention in the scientific community, contributing to the development of new therapeutic strategies.
Collaborations
Some of his notable coworkers include Jean-Christophe Renauld and Muriel Lemaire, who collaborate with him on various projects within the field of biotechnology.
Conclusion
Laurie Dumoutier's work in antibody production exemplifies the innovative spirit of modern biotechnology. His patents and collaborations highlight the importance of research in developing new medical solutions.